This is an AMP page which is for mobile devices.

View Non AMP page

Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / LH - LabCorp partner Geneoscopy wins FDA approval of colorectal cancer test ColoSense

LH - LabCorp partner Geneoscopy wins FDA approval of colorectal cancer test ColoSense

May, 06 2024 04:35 PM Laboratory Corporation of America Holdings

2024-05-06 16:35:21 ET

More on LabCorp

Laboratory Corporation of America Holdings (LH) Q1 2024 Earnings Call Transcript
Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Laboratory Corporation of America Holdings (LH) Q4 2023 Earnings Call Transcript
Quest Diagnostics, LabCorp climb following FDA testing oversight rule
Labcorp’s companion diagnostic approved for use with Pfizer’s hemophilia B gene therapy

For further details see:

LabCorp partner Geneoscopy wins FDA approval of colorectal cancer test ColoSense

Stock Information

Company Name:	Laboratory Corporation of America Holdings
Stock Symbol:	LH
Market:	NYSE
Website:	labcorp.com

LH LH Quote LH Short LH News LH Articles LH Message Board

Get LH Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.